Admixture of heparin with urokinase to decrease thrombolysis time and urokinase dose in polytetrafluoroethylene dialysis graft recanalization

J Vasc Interv Radiol. 1996 Mar-Apr;7(2):193-7. doi: 10.1016/s1051-0443(96)70761-3.

Abstract

Purpose: To determine whether the addition of heparin to urokinase during dialysis graft thrombolysis can lower urokinase dose and shorten procedure time.

Patients and methods: Patients who underwent dialysis graft thrombolysis during an 18-month period were studied retrospectively. Twenty patients were treated with urokinase alone, and 19 patients were treated with urokinase and heparin. Thrombolysis was performed in the angiography suite by using a crossed-catheter technique. Urokinase was administered directly into the thrombus. In patients receiving heparin, 5,000 IU was added directly to the initial urokinase solution.

Results: In patients who received urokinase alone, an average of 750,000 U of urokinase was used, and the average procedure time was 2 hours 42 minutes. When heparin was added, an average of 435,000 U of urokinase was used, and the average procedure time was 2 hours.

Conclusion: The addition of heparin to urokinase can decrease both urokinase dose and thrombolysis time in the recanalization of dialysis grafts.

Publication types

  • Comparative Study

MeSH terms

  • Arteriovenous Shunt, Surgical
  • Blood Vessel Prosthesis
  • Case-Control Studies
  • Drug Combinations
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Graft Occlusion, Vascular / drug therapy*
  • Heparin / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Polytetrafluoroethylene
  • Renal Dialysis*
  • Retrospective Studies
  • Thrombolytic Therapy / methods*
  • Thrombosis / drug therapy*
  • Time Factors
  • Urokinase-Type Plasminogen Activator / administration & dosage*

Substances

  • Drug Combinations
  • Fibrinolytic Agents
  • Polytetrafluoroethylene
  • Heparin
  • Urokinase-Type Plasminogen Activator